← Back to catalogue

Axsym Core-M 2.0 (LN 3B89)

FDA PMA

Class II (US FDA PMA)

PMA P060009

by Abbott Laboratories, Inc.

Identity

Trade Name
AXSYM CORE-M 2.0 AND AXSYM CORE-M 2.0 CONTROLS FDA PMA
Generic Name
Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen) FDA PMA

Identifiers

PMA Number
P060009 FDA PMA
FDA Product Code
LOM FDA PMA

Classification

Device Class
Class II FDA PMA
Legislation / Framework
21 CFR Part 866.3172 FDA PMA
Regulation Number
866.3172 FDA PMA
Advisory Committee
Microbiology FDA PMA
FDA Decision
APWD FDA PMA

The Axsym Core-M 2.0 is a microparticle enzyme immunoassay (MEIA) intended for the in vitro qualitative detection of IgM antibody to hepatitis B virus core antigen (IgM anti-HBC) in serum or plasma. This assay aids in diagnosing acute or recent hepatitis B virus (HBV) infection when used alongside other laboratory results and clinical information.

The Axsym Core-M 2.0 is supplied as a reagent pack for use with the Axsym system and is intended for single-use in clinical microbiology laboratories. It requires no special storage conditions beyond those specified in the accompanying instructions and is regulated under FDA Premarket Approval (PMA P060009). Controls for the Axsym Core-M 2.0 are provided to monitor system performance when using the specified reagent pack.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_PMA

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA PMA P060009 24 fields · synced Sep 18, 2026